Dynavax Technologies Corporation (NASDAQ:DVAX) surged 8% Thursday following the announcement of encouraging topline data from ...

GSK plc has announced the acquisition of American Depositary Shares (ADSs) by two of its executives, Dr. Hal Barron and James Ford, through reinvestment of dividends in their respective savings plans.

In conclusion, GlaxoSmithKline's shares showed significant gains today, reflecting positive market sentiment and strong ...

With the stock currently priced at Rs 2,724.90, GlaxoSmithKline Pharmaceuticals shows significant activity in today's session ...

GlaxoSmithKline's chief executive officer said in an email to the company’s employees that Slaoui’s name would be removed from its research and development facility in Rockville, Md.

GlaxoSmithKline’s (GSK) materially understated profits and alarming and material disclosures in the 10-Ks of Squarespace (SQSP), VBI Vaccines (VBIV), and Research Frontiers (REFR).

Activist investor Elliott Management Corp. has intensified pressure on GlaxoSmithKline PLC,GSK-3.84%decrease; red down pointing triangle calling on the pharmaceutical giant to replace members of ...

Sanofi, GlaxoSmithKline pledge 200M COVID-19 vaccines for global use By Noah Manskar Published Oct. 28, 2020, 11:41 a.m. ET ...

GlaxoSmithKline today participated in a U.S. Food and Drug Administration (FDA) advisory committee meeting convened to discuss recent findings of porcine circovirus (PCV) in rotavirus vaccines.

GlaxoSmithKline is accused in a lawsuit of using threats to block generic competition to its $2-billion-a-year antibiotic Augmentin after a U.S. judge eliminated the drug's patent protection.

GlaxoSmithKline, the camel-cased conglomerate behind such pharmaceutical hits as Wellbutrin and Levitra, has s igned on with the service to conduct rheumatoid arthritis research.